Publications

5808 Results

High incidence of thrombotic events observed in patients receiving lenalidomide (L) + dexamethasone (D) (LD) as first-line therapy for multiple myeloma (MM) without aspirin (ASA) prophylaxis

Authors
JA Zonder;BGM Durie;J McCoy;J Crowley;JB Zeldis;L Ghannam;B Barlogie
Journal / Conference
Blood (ASH Annual Meeting Abstracts) 106(11): #3455
Year
2005
Research Committee(s)
Myeloma
Study Number(s)
S0232

International staging system for multiple myeloma

Authors
PR Greipp;J San Miguel;BGM Durie;JJ Crowley;B Barlogie;J Blade;M Boccadoro;JA Child;H Avet-Loiseau;RA Kyle;JJ Lahuerta;H Ludwig;G Morgan;R Powles;K Shimizu;C Shustik;P Sonneveld;P Tosi;I Turesson;J Westin
Journal / Conference
Journal of Clinical Oncology 23(15):3412-3420
Year
2005
Research Committee(s)
Myeloma
PMID
PMID15809451

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

Authors
EH Romond;EA Perez;J Bryant;VJ Suman;CE Geyer, Jr;NE Davidson;E Tan-Chiu;S Martino;S Paik;PA Kaufman;SM Swain;TM Pisansky;L Fehrenbacher;LA Kutteh;VG Vogel;DW Visscher;G Yothers;RB Jenkins;AM Brown;SR Dakhil;E Mamounas;WL Lingle;PM Klein;JN Ingle;N Wolmark
Journal / Conference
New England Journal of Medicine 353(16):1673-1684
Year
2005
Research Committee(s)
Breast
Study Number(s)
N9831

Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures

Authors
D Mahadevan;C Spier;K Della Croce;S Miller;B George;C Riley;S Warner;TM Grogan;TP Miller
Journal / Conference
Molecular Cancer Therapeutics 4(12):1867-1879
Year
2005
Research Committee(s)
Lymphoma
PMID
PMID16373702

Individual prediction of prostate cancer based on prostate specific antigen

Authors
C Chi;D Pauler Ankerst;P Goodman
Journal / Conference
Clinical Trials 2 (Suppl 1):P40
Year
2005
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Gene expression distinguishes Burkitt Lymphoma from other aggressive lymphomas and identifies patients who are highly curable with intensive chemotherapeutic regimens

Authors
SS Dave;K Fu;G Wright;L Lam;TC Greiner;DD Weisenberger;PM Kluin;E Boerma;A Rosenwald;G Ott;HK Muller-Hermelink;RD Gascoyne;J Delabie;LM Rimsza;RM Braziel;TM Grogan;E Campo;ES Jaffe;J Vose;JO Armitage;JM Connors;EB Smeland;S Kvaloy;H Holte;TP Miller;RI Fisher;E Montserrat;WH Wilson;M Bahl;H Zhao;L Yang;J Powell;R Simon;WC Chan;LM Staudt
Journal / Conference
Blood 106(11):#415
Year
2005
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8819

S9900: Preliminary "surgical" results of a phase III trial of surgery alone or surgery plus preoperative (preop) paclitaxel/carboplatin (PC) chemotherapy in early stage non-small cell lung cancer (NSCLC)

Authors
E Vallieres;KMW Pisters;J Crowley;K Chansky;P Bunn;D Gandara
Journal / Conference
Lung Cancer 49 (Suppl 2):S43 (0-124)
Year
2005
Research Committee(s)
Lung
Study Number(s)
S9900

Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial

Authors
RD Etzioni;N Howlader;PA Shaw;DP Ankerst;DF Penson;PJ Goodman;IM Thompson
Journal / Conference
Journal of Urology 174:877-881
Year
2005
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Incidence, outcomes, and SNP genotypes show different ethnic association in patients with myeloma, assessed in SWOG and ECOG clinical trials S9321 and E9486: from the Bank on a Cure

Authors
B Van Ness;J Crowley;C Ramos;S Grindle;E Rasmussen;E Blood;A Hoering;B Barlogie;P Greipp;B Durie
Journal / Conference
Blood (ASH Annual Meeting Abstracts) 106(11): #506
Year
2005
Research Committee(s)
Myeloma
Study Number(s)
SWOG-9321

SNP genotypes show association with common toxicities during both VAD induction and high dose melphalan with autologous transplant support in Intergroup trial S9321 for myeloma: from the bank on a cure

Authors
BG Van Ness;JC Crowley;C Ramon;S Grindle;E Rasmussen;A Hoering;P Greipp;B Barlogie;B Durie
Journal / Conference
Blood (ASH Annual Meeting Abstracts) 106(11): #3488
Year
2005
Research Committee(s)
Myeloma
Study Number(s)
SWOG-9321